计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| T135203-200mg |
200mg |
现货 ![]() |
| |
| T135203-250mg |
250mg |
现货 ![]() |
| |
| T135203-1g |
1g |
现货 ![]() |
| |
| T135203-5g |
5g |
期货 ![]() |
|
| 别名 | 3-异丁基-9,10-二甲氧基-1,3,4,6,7,11b-六氢-2H-苯并[a]喹啉-2-酮 |
|---|---|
| 英文别名 | FT-0771873 | CHEBI:9467 | tetra Benazin | 2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)- | NCGC00160421-02 | Rubigen | 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-Benzo[a]quinolizin-2-one | 2H-Benz |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Tetrabenazine |
| 生化机理 | Tetrabenazine 是一种可逆的 2 型囊泡单胺转运体(VMAT)抑制剂。它是一种强效、可逆的 VMAT2 抑制剂(IC 50 = 3.2 nM,K i = 100 nM)。它能消耗储存的单胺类物质,减少突触小泡的摄取。在体内具有抗过度运动的作用。口服有效。 |
| 应用 | Usually used for dopamine uptake assays in mouse brain cells,and also has been used for non-specific binding assays in postnuclear supernatants derived from PC-12 and CV-1 cells. |
| 储存温度 | 2-8°C储存 |
| 运输条件 | 冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 囊泡单胺转运体 1 抑制剂;囊泡单胺转运体 2 抑制剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
Usually used for dopamine uptake assays in mouse brain cells,and also has been used for non-specific binding assays in postnuclear supernatants derived from PC-12 and CV-1 cells. Usually used for dopamine uptake assays in mouse brain cells,and also has been used for non-specific binding assays in postnuclear supernatants derived from PC-12 and CV-1 cells. |
| 纯度 | ≥98% |
| ALogP | 2.9 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504750984 |
|---|---|
| EC号 | 200-383-6 |
| 分子类型 | 小分子 |
| IIUPAC Name | 9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one |
| INCHI | 1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3 |
| InChi Key | MKJIEFSOBYUXJB-UHFFFAOYSA-N |
| Smiles | CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC |
| Isomeric SMILES | CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC |
| PubChem CID | 6018 |
| 分子量 | 317.42 |
| Beilstein号 | 40090 |
| 敏感性 | 对空气敏感,对热敏感 |
|---|---|
| 熔点 | 127 °C |
| 分子量 | 317.400 g/mol |
| XLogP3 | 2.900 |
| 氢键供体数Hydrogen Bond Donor Count | 0 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 4 |
| 精确质量Exact Mass | 317.199 Da |
| 单同位素质量Monoisotopic Mass | 317.199 Da |
| 拓扑极表面积Topological Polar Surface Area | 38.800 Ų |
| 重原子数Heavy Atom Count | 23 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 425.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 2 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| WGK Germany | 3 |
| RTECS | DK2275000 |
| Merck Index | 9182 |
| 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
| 1. Jankovic J. (2016) Dopamine depleters in the treatment of hyperkinetic movement disorders.. Expert Opin Pharmacother, 17 (18): (2461-2470). [PMID:27819145] |
| 2. Yuewei Bi, Pengfei Wang, Min Li, Zhuyong Wang, Siyuan Lv, Yong Yang, Wangming Zhang. (2025) Electrophysiological Alterations in the Progression of Parkinson's Disease and the Therapeutic Effect of Tetrabenazine on Rats With Levodopa-Induced Dyskinesia. CNS Neuroscience & Therapeutics, 31 (2): (e70250). [PMID:39912385] [10.1111/cns.70250] |